Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.
All content for Cleveland Clinic Cancer Advances is the property of Cleveland Clinic Taussig Cancer Institute and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.
Advances in the Management of Metastatic Bone Disease
Cleveland Clinic Cancer Advances
17 minutes
2 months ago
Advances in the Management of Metastatic Bone Disease
Orthopedic Oncologist at Cleveland Clinic in Florida, Jorge Manrique-Succar, MD, returns to the Cancer Advances Podcast to share the latest advances in treating metastatic bone disease. Listen as Dr. Manrique talks about early intervention, advanced surgical techniques, and multidisciplinary collaboration are improving outcomes for cancer patients with skeletal-related complications.
Cleveland Clinic Cancer Advances
Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.
